BAY Share Price

Open 107.50 Change Price %
High 108.00 1 Day 0.70 0.66
Low 107.00 1 Week 1.30 1.23
Close 107.20 1 Month 2.90 2.78
Volume 1039 1 Year 4.70 4.59
52 Week High 113.00
52 Week Low 83.80
BAY Important Levels
Resistance 2 108.13
Resistance 1 107.75
Pivot 107.40
Support 1 106.66
Support 2 106.27
BIT Italy Most Active Stocks
SPM 0.42 5.00%
SPM 0.42 5.00%
ISP 2.53 0.00%
TIT 0.85 0.00%
PMI 0.36 0.00%
PMI 0.36 0.00%
ZUC 0.03 0.00%
ENEL 4.33 0.46%
F 6.94 -2.12%
F 6.94 -2.12%
More..
BIT Italy Top Gainers Stocks
PGR 300.00 20.00%
PGR 300.00 20.00%
PGR 300.00 20.00%
PGR 300.00 20.00%
ECA 0.07 16.67%
ECA 0.07 16.67%
ECA 0.07 16.67%
KRE 0.53 12.77%
MON 0.23 9.52%
MON 0.23 9.52%
More..
BIT Italy Top Losers Stocks
RIC 0.23 -8.00%
RIC 0.23 -8.00%
RIC 0.23 -8.00%
RIC 0.23 -8.00%
IIN 0.20 -4.76%
IIN 0.20 -4.76%
IIN 0.20 -4.76%
SPMR 4.55 -4.21%
LR 0.48 -4.00%
LR 0.48 -4.00%
More..

Bayer AG (BIT: BAY)

BAY Technical Analysis 5
As on 28th Mar 2017 BAY Share Price closed @ 107.20 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 95.53 & Strong Buy for SHORT-TERM with Stoploss of 104.76 we also expect STOCK to react on Following IMPORTANT LEVELS.
BAY Target for March
1st Target up-side 108.44
2nd Target up-side 111.35
3rd Target up-side 114.25
1st Target down-side 100.16
2nd Target down-side 97.25
3rd Target down-side 94.35
BAY Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.bayer.com
BAY Address
BAY
Kaiser-Wilhelm-Allee 1
Leverkusen, 51368
Germany
Phone: 49 214 301
BAY Latest News
Bayer, Icagen Partner on X-Ray Fluorescence Assays   Genetic Engineering & Biotechnology News   - 28th Mar 17
Syngenta interested in assets from Bayer, Monsanto deal   St. Louis Business Journal   - 28th Mar 17
Bayer's closing comments to Rev & Tax on taxing groceries: 'Not the best ...   The Spokesman-Review (blog)   - 28th Mar 17
Bayer: 'It allows people to have the money up-front'   The Spokesman-Review (blog)   - 28th Mar 17
Bayer Partnering Deals and Alliances 2010 to 2017   Yahoo Finance   - 28th Mar 17
Syngenta Eyes Bayer Assets in Whirlwind of Agrochem Deals   Bloomberg   - 27th Mar 17
Bayer Park marks grand opening as a cultural crossroads in southwest Santa Rosa   Santa Rosa Press Democrat   - 26th Mar 17
Wicker Park Capital Management hires Bayer Vice President to lead new ...   AL.com   - 23rd Mar 17
Bayer to Showcase Data on Growing Oncology Pipeline at AACR 2017   PR Newswire (press release)   - 22nd Mar 17
Bayer Said to Plan Sales of Seed Assets to Pre-empt Regulators   Bloomberg   - 17th Mar 17
Interactive Technical Analysis Chart Bayer AG ( BAY BIT Italy )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Bayer AG
BAY Business Profile
Bayer Aktiengesellschaft develops, produces, and markets health care and agricultural products, and high-tech polymer materials worldwide. The company operates through HealthCare, CropScience, and MaterialScience segments. The HealthCare segment offers prescription pharmaceuticals, such as contraceptives, hemophilia treatments, anticoagulants, and medicines to treat multiple sclerosis, cancer, hypertension, and infectious diseases; and consumer health products comprising over-the-counter medications, dermatology products, nutritional supplements, veterinary medicines, and animal grooming products. This segment also provides medical care products, including blood glucose monitoring devices, such as single-strip and multi-strip systems; USB meters that feature integrated diabetes management software and direct plug-in to computers; contrast agent injection systems for diagnostic and therapeutic medical procedures in computed tomography, magnetic resonance imaging, and molecular imaging; and mechanical systems for removing thrombi from blood vessels, as well as service products for its systems. The CropScience segment offers products for use in agriculture as insecticides, fungicides, and herbicides or seed treatments; seeds and plant traits; and various products for gardens, green industry, and nonagricultural pest control. The MaterialScience segment provides high-tech polymer materials in the areas of polyurethanes, polycarbonates, coating and adhesive raw materials, and functional films; and produces and markets inorganic basic chemicals. The company has a strategic alliance with OncoMed Pharmaceuticals, Inc. to develop drugs to target cancer stem cell therapeutics. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.